Ease of Use of the Reusable DuraTouch Pen Injector in Individuals with Diabetes with and Without Previous Pen Injector Experience: A Handling Study.

IF 6.3 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Shahid Akhtar, Anya Sonia Wernersson, Birgitte Berg, Jonathan Comins, Anne-Marie Barkley Jessen, Bastian Gaardsvig Kjeldsen, Sascha Kopic, Niklas Kahr Rasmussen, Elisabeth Rundell, Gitte Ter-Borch, Thomas Sparre
{"title":"Ease of Use of the Reusable DuraTouch Pen Injector in Individuals with Diabetes with and Without Previous Pen Injector Experience: A Handling Study.","authors":"Shahid Akhtar, Anya Sonia Wernersson, Birgitte Berg, Jonathan Comins, Anne-Marie Barkley Jessen, Bastian Gaardsvig Kjeldsen, Sascha Kopic, Niklas Kahr Rasmussen, Elisabeth Rundell, Gitte Ter-Borch, Thomas Sparre","doi":"10.1177/15209156251363465","DOIUrl":null,"url":null,"abstract":"<p><p>This single-arm handling study assessed whether the reusable DuraTouch® pen injector is easy to use and easy to learn how to use in adults with type 1 diabetes (T1D) or type 2 diabetes (T2D) with or without prior pen injector experience. Following a 15-min training session, participants were instructed to independently administer a simulated DuraTouch injection. Of the 100 included participants (91% with T2D, 9% with T1D), 50% had prior pen injector experience. Pen injector-naive participants required more training time than pen injector-experienced participants (median time, 11 vs. 9 min, respectively). Overall, 85% of participants found DuraTouch very easy or extremely easy to use (using the Diabetes Pen Experience Measure), and 87% found it easy or very easy to learn how to use (using the Injection Device Experience and Acceptability questionnaire). DuraTouch may be a viable pen injector alternative for individuals with diabetes, irrespective of prior pen injector experience.</p>","PeriodicalId":11159,"journal":{"name":"Diabetes technology & therapeutics","volume":" ","pages":""},"PeriodicalIF":6.3000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes technology & therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15209156251363465","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

This single-arm handling study assessed whether the reusable DuraTouch® pen injector is easy to use and easy to learn how to use in adults with type 1 diabetes (T1D) or type 2 diabetes (T2D) with or without prior pen injector experience. Following a 15-min training session, participants were instructed to independently administer a simulated DuraTouch injection. Of the 100 included participants (91% with T2D, 9% with T1D), 50% had prior pen injector experience. Pen injector-naive participants required more training time than pen injector-experienced participants (median time, 11 vs. 9 min, respectively). Overall, 85% of participants found DuraTouch very easy or extremely easy to use (using the Diabetes Pen Experience Measure), and 87% found it easy or very easy to learn how to use (using the Injection Device Experience and Acceptability questionnaire). DuraTouch may be a viable pen injector alternative for individuals with diabetes, irrespective of prior pen injector experience.

可重复使用DuraTouch笔式注射器在有或没有笔式注射器使用经验的糖尿病患者中的易用性:一项处理研究。
这项单臂操作研究评估了可重复使用的DuraTouch®笔式注射器在有或没有笔式注射器经验的1型糖尿病(T1D)或2型糖尿病(T2D)患者中是否易于使用和易于学习。在15分钟的训练之后,参与者被要求独立地进行模拟的DuraTouch注射。在纳入的100名参与者中(91%为T2D, 9%为T1D), 50%有过笔式注射器的经验。新手参与者比有经验的参与者需要更多的训练时间(中位数时间分别为11分钟和9分钟)。总体而言,85%的参与者认为DuraTouch非常容易或非常容易使用(使用糖尿病笔体验测量),87%的参与者认为它很容易或非常容易学习如何使用(使用注射设备体验和可接受性问卷)。对于糖尿病患者来说,DuraTouch可能是一种可行的笔式注射器替代方案,无论他们是否有过笔式注射器的使用经验。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes technology & therapeutics
Diabetes technology & therapeutics 医学-内分泌学与代谢
CiteScore
10.60
自引率
14.80%
发文量
145
审稿时长
3-8 weeks
期刊介绍: Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信